An expert oncologist reviews a patient case of metastatic urothelial carcinoma and provides insights on the latest treatment updates in targeted therapy.
EP. 1: Patient Case: A 73-Year-Old Man With Metastatic Urothelial Carcinoma
Arlene Siefker-Radtke, MD, discusses the nuanced treatment journey of a 73-year-old man with metastatic bladder cancer, highlighting the challenges and evolving strategies in his case.
EP. 2: Challenges in Treating Metastatic Urothelial Cancer: A Geriatric Perspective
Expert insight into the complexities of managing metastatic urothelial cancer in geriatric patients with comorbidities, highlighting the importance of aggressive therapy in improving survival outcomes.
EP. 3: Biomarker Testing in Urothelial Cancer: Implications for Treatment Decisions
The evolving role of biomarker testing, including PD-L1 expression and mutations like FGFR3, in guiding treatment decisions for urothelial cancer patients, shedding light on their clinical significance and potential impact on therapeutic choices.
EP. 4: Early Mutation Profiling in Urothelial Cancer: A Path to Targeted Therapy
Arlene Siefker-Radtke, MD, emphasizes the importance of early mutation profiling in metastatic urothelial cancer and highlights the potential for targeted agents and clinical trials to improve treatment outcomes.
EP. 5: Frontline Options for Metastatic Urothelial Cancer: Tailoring Treatment Choices
Diverse approaches to frontline treatment for metastatic urothelial cancer, including eligibility for cisplatin-based chemotherapy, alternative regimens, and the impact of drug shortages on treatment decisions.
EP. 6: Second-Line Strategies in Metastatic Urothelial Cancer: Balancing Options and Risks
Arlene Siefker-Radtke, MD, delves into the complexities of managing progressive disease in metastatic urothelial cancer, outlining considerations for immune checkpoint inhibitors, antibody drug conjugates, and other targeted therapies.
EP. 7: Navigating Neuropathy in Urothelial Cancer Treatment
Expert perspective on the impact of neuropathy on treatment choices in urothelial cancer, providing insight into identifying and managing peripheral neuropathy and exploring suitable treatment options.
EP. 8: Future Directions in Urothelial Cancer Treatment: Clinical Trials and Novel Agents
Arlene Siefker-Radtke, MD, highlights the ongoing quest for improved treatment options in metastatic urothelial cancer, emphasizing the role of clinical trials and novel agents in addressing unmet needs.
2 Clarke Drive Cranbury, NJ 08512